Aimovig (erenumab-aooe) - Amgen
Vyepti (eptinezumab-jjmr) - Teva, Lundbeck
Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo, Organon
Ajovy (fremanezumab-vfrm) - Teva
Qulipta (atogepant) - AbbVie
Nurtec ODT (rimegepant ODT) - Pfizer
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957
 
Starling, A.J.1; Regnier, S.2; Soni-Brahmbhatt, S.2; Awad, S.F.3; Grossman, S.2; Eisenberg, D.2; Townshend, M.4; Estemalik, E.5
 
Jun 14, 2025
 
Next